Search

Your search for "qyresearch china chronic lymphocytic leukemia cll therapeutics devices market research report 2017" gave back 220456 results.
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog: 
Global Markets Direct
May 2018
Price: USD 2,000.00
Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog: 
Global Markets Direct
October 2021
Price: USD 2,500.00
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog: 
Global Markets Direct
November 2020
Price: USD 2,500.00
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog: 
Global Markets Direct
December 2019
Price: USD 2,000.00
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog: 
Global Markets Direct
May 2020
Price: USD 2,500.00
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global...
Catalog: 
Global Markets Direct
October 2022
Price: USD 2,500.00
Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for...
LPI
March 2023
Price: USD 3,660.00
Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for...
MRRPB5
October 2023
Price: USD 2,900.00
Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for...
MRRPB5
February 2024
Price: USD 2,900.00
Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) -...
Catalog: 
Global Markets Direct
April 2021
Price: USD 2,000.00
Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology...
Catalog: 
Global Markets Direct
April 2021
Price: USD 2,000.00
Relapsed Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Relapsed Chronic...
Catalog: 
Global Markets Direct
May 2022
Price: USD 2,500.00
Refractory Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Refractory...
Catalog: 
Global Markets Direct
May 2022
Price: USD 2,500.00
Chronic lymphocytic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). Chronic...
Catalog: 
MRRPB5
January 2024
Price: USD 2,900.00
Accumulation of functionally incompetent monocytes is referred as Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia is a type of...
MRRPB5
April 2023
Price: USD 2,900.00

Contact Us for Custom Market Research Solutions

 

Custom Market Research Reports

Filter By Industry

Filter By Country

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected